Search Team

Search by Last Name
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
 
Headshot

Veronica Sandoval, Ph.D.

Associate

San Diego, CA
858-678-4331
sandoval@fr.com
Download vCard

Background

Dr. Veronica Sandoval is a litigation Associate in the San Diego office. Dr. Sandoval earned her Ph.D. in Pharmacology & Toxicology, with a focus in neuropharmacology, from the University of Utah. Dr. Sandoval’s doctorate research focused on the neurotoxic effects of methamphetamine on the neurochemistry and dopaminergic system; her research had implications for drug addiction treatment and Parkinson’s disease. Dr. Sandoval is the author and co-author of numerous peer-reviewed scientific journal articles.

Dr. Sandoval attended Seattle University School of Law. She served as a Judicial Extern to Honorable Charles K. Wiggins of the Washington Supreme Court and as an extern at the United States Patent and Trademark Office. Prior to law school, Dr. Sandoval was employed as a Medical Liaison for two different pharmaceutical companies and was an Adjunct Professor at the University of Utah in the Department of Pharmacology & Toxicology.

Education

J.D., Seattle University School of Law 2013
cum laude


Ph.D., University of Utah 2002
Pharmacology & Toxicology (Neuropharmacology focus)
Ford Foundation Fellowship; The Gates Millennium Scholarship; Neuroscience Scholars Program


University of California, Berkeley 1997
Molecular and Cell Biology
Minor: Spanish Literature
Howard Hughes Research Grant

Admissions

  • U.S. Patent and Trademark Office 2008
  • Washington 2014
  • California 2015

Languages

  • English
  • Spanish

Memberships & Affiliations

​San Diego Intellectual Property Association
American Bar Association
Lawyers Club of San Diego

Other Distinctions

Accolades
CALI Awards : Intellectual Property Licensing Lab, Environmental Law Fundamentals, Mediation Clinic, Mass Media Law and Policy

Publications

Morgan, J. and Sandoval, V. Pacific Northwest Perspective: The Impact of the America Invents Act on Nonprofit Global Health Organizations, 9 WASH J.L. TECH. &ARTS 177 (2014) http://digital.law.washington.edu/dspace-law/handle/1773.1/1328.

Hanson, G.R., Sandoval, V., Riddle, E., Fleckenstein, and A.E. Psychostimulants and Vesicle Trafficking: A Novel Mechanism and Therapeutic Implications. Ann N Y Acad Sci. (2004) 1025: 146-150.

Sandoval, V., Riddle, E.R., Hanson, G.R., Fleckenstein, A.E. Methylphenidate Alters Vesicular Monoamine Transport and Prevents Methamphetamine-Induced Dopaminergic Deficits. J Pharmacol Exp Ther. (2003) 304(3): 1181-1187.

Fleckenstein, A.E., Brown, J.M., Sandoval, V., Riddle, E.L., Hansen, J.P., Ugarte, Y.V., Gibb, J.W., and Hanson, G.R. D2 Receptor-Mediated Regulation of Vesicular Dopamine Uptake. Catecholamine Research: From Molecular Insights to Clinical Medicine, Kluwer Academic/Plenum Publishers (2002) 53: 39-42.

Metzger R.R., Brown J.M., Sandoval V., Rau K.S., Elwan M.A., Miller G.W., Hanson G.R., and Fleckenstein A.E. Inhibitory Effect of Reserpine on Dopamine Transporter Function. Eur J Pharmacol. (2002) 456(1-3): 39-43.

Sandoval, V., Riddle, E.R., Hanson, G.R., Fleckenstein, A.E. Methylphenidate Redistributes Vesicular Monoamine Transporter-2 Immunoreactivity: Role of Dopamine Receptors. J Neurosci. (2002) 22(19): 8705-8710.

Brown, J.M., Riddle, E.L., Sandoval, V., Weston, R.K., Hanson, J.E., Crosby, M.J., Hanson, G.R., Fleckenstein, A.E. A Single Methamphetamine Administration Rapidly Decreases Vesicular Dopamine Uptake. J Pharmacol Exp Ther. (2002) 302(2): 497-501.

Hansen, J.P., Riddle, E.L., Sandoval, V., Brown, J.M., Hanson, G.R., and Fleckenstein, A.E. Methylenedioxyamphetamine Decreases Plasmalemmal and Vesicular Dopamine Transport: Mechanisms and Implications for Neurotoxicity. J Pharmacol Exp Ther. (2002) 300(3): 1093-1100.

Sandoval, V., Riddle E.L., Ugarte Y.V., Hanson, G.R., and Fleckenstein, A.E. Methamphetamine-Induced Rapid and Reversible Changes in Dopamine Transporter Function: An In Vitro Model. J Neurosci. (2001) 21(4): 1413-1419.

Sandoval, V., Hanson, G.R., and Fleckenstein, A.E. Methamphetamine Decreases Mouse Striatal Dopamine Transporter Activity: Roles of Hyperthermia and Dopamine. Eur J Pharmacol. (2000) 409(3): 265-271.

Harris, J.N., Dick, M., Sandoval, V., Gallegos, D., Lozano, S., Rangel, S., and Kean, M.L. Verbal and Motor Memory in Alzheimer’s Disease: Release From Proactive Inhibition. Progress in Alzheimer’s and Parkinson’s Diseases, Adv Behavioral Bio. (1998) 9: 309-315.